TIDMWLFE
RNS Number : 3490G
Wolf Minerals Limited
20 November 2015
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement,
application for quotation of additional securities
and agreement
Information or documents not available now must be given to ASX
as soon as available. Information and documents given to ASX become
ASX's property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98,
01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05,
01/08/12, 04/03/13
Name of entity
WOLF MINERALS LIMITED
-------------------------
ABN
11 121 831 472
----------------------------
We (the entity) give ASX the following information.
Part 1 -- All issues
You must complete the relevant sections (attach sheets if there
is not enough space).
1 +Class of +securities a) Fully Paid Ordinary Shares
issued or to be issued b) Performance Rights
2 Number of +securities a) 124,593 Fully Paid Ordinary
issued or to be issued Shares
(if known) or maximum b) 1,982,545 Performance Rights
number which may be
issued
3 Principal terms of Fully Paid Ordinary Shares
the +securities (e.g. a) 124,593 ordinary shares issued
if options, exercise to the Company's Non-Executive
price and expiry date; Directors under the Wolf Minerals
if partly paid +securities, Limited Directors' Share Plan
the amount outstanding approved by shareholders at
and due dates for the Company's Annual General
payment; if +convertible Meeting on 21 November 2014
securities, the conversion and on 16 November 2015
price and dates for Performance Rights
conversion) b) The performance rights are
issued in accordance with the
Wolf Minerals Limited Performance
Rights Plan, as re-adopted by
shareholders on 21 November
2014. The vesting date is 30
June 2018. Upon vesting, one
performance right is converted
into one fully paid ordinary
share in the Company for nil
cash consideration. Vesting
is subject to the following
conditions:
(i) 50% of performance rights
will vest based on the Company's
relative share price performance
versus the AIM Basic Resources
Index in accordance with a defined
scale; and
(ii) 50% of performance rights
will vest based upon the Company's
Total Shareholder Return (TSR)
performance as measured from
1 July 2015 to the vesting date
of 30 June 2018.
---------------------------------------------------
4 Do the +securities Fully Paid Ordinary Shares
rank equally in all a) Yes - equally in all respects
respects from the with quoted securities WLF
+issue date with an Fully Paid Ordinary Shares
existing +class of
quoted +securities? Performance Rights
If the additional b) No (not until vesting).
+securities do not Prior to vesting the performance
rank equally, please rights do not carry a right
state: to vote, receive dividends
* the date from which they do or generally participate in
other corporate actions. However
ordinary shares allocated
* the extent to which they participate for the next upon vesting of the performance
dividend, (in the case of a trust, distribution) or rights will rank equally with
interest payment all existing fully paid ordinary
shares on issue.
* the extent to which they do not rank equally, other
than in relation to the next dividend, distribution
or interest payment
---------------------------------------------
5 Issue price or consideration Fully Paid Ordinary Shares
a) Non-cash consideration of
A$0.3371 per share.
Performance Rights
b) Nil
---------------------------------------------
Purpose of the issue a) Ordinary shares issued to
(If issued as consideration the Company's Non-Executive
6 for the acquisition Directors under the Wolf Minerals
of assets, clearly Limited Directors' Share Plan
identify those assets) approved by shareholders at
the Company's Annual General
Meeting on 21 November 2014
and 16 November 2015.
b) The performance rights have
been issued to the Managing
Director, Mr Russell Clark,
and other senior executives
under the Wolf Minerals Limited
Performance Rights Plan to provide
an appropriate remuneration
strategy and incentive for the
Managing Director and senior
executives to achieve the prescribed
performance milestones set by
the Board.
-----------------------------------------------
Is the entity an +eligible Yes
entity that has obtained
6a security holder approval
under rule 7.1A?
If Yes, complete sections
6b - 6h in relation
to the +securities
the subject of this
Appendix 3B, and comply
with section 6i
-----------------------------------------------
The date the security 16 November 2015
holder resolution
6b under rule 7.1A was
passed
-----------------------------------------------
Number of +securities Nil
issued without security
6c holder approval under
rule 7.1
-----------------------------------------------
Number of +securities Nil
(MORE TO FOLLOW) Dow Jones Newswires
November 20, 2015 02:00 ET (07:00 GMT)
issued with security
6d holder approval under
rule 7.1A
-----------------------------------------------
Number of +securities Nil
issued with security
6e holder approval under
rule 7.3, or another
specific security
holder approval (specify
date of meeting)
-----------------------------------------------
Number of +securities 124,593 Ordinary Shares
issued under an exception
6f in rule 7.2
-----------------------------------------------
If +securities issued N/A
under rule 7.1A, was
6g issue price at least
75% of 15 day VWAP
as calculated under
rule 7.1A.3? Include
the +issue date and
both values. Include
the source of the
VWAP calculation.
-----------------------------------------------
If +securities were N/A
issued under rule
6h 7.1A for non-cash
consideration, state
date on which valuation
of consideration was
released to ASX Market
Announcements
-----------------------------------------------
Calculate the entity's
remaining issue capacity
under rule 7.1 and
rule 7.1A - complete
Annexure 1 and release
6i to ASX Market Announcements 202,386,698
-----------------------------------------------
7 +Issue dates 20 November 2015
Note: The issue date
may be prescribed
by ASX (refer to the
definition of issue
date in rule 19.12).
For example, the issue
date for a pro rata
entitlement issue
must comply with the
applicable timetable
in Appendix 7A.
Cross reference: item
33 of Appendix 3B.
Number +Class
---------------------- -----------------------
Number and +class
of all +securities
quoted on ASX (including
the +securities in Fully Paid Ordinary
8 section 2 if applicable) 809,546,793 Shares
---------------------- -----------------------
Number +Class
------------ -------------------------------
Unlisted options exercisable
at $0.34 on or before
30 November 2015.
Unlisted options exercisable
at $0.333 on or before
1 January 2016.
Unlisted options exercisable
at $0.3898 on or before
1 January 2016.
Unlisted options exercisable
at $0.333 on or before
30 January 2016.
Unlisted options exercisable
at $0.3898 on or before
30 January 2016.
Unlisted options exercisable
at $0.264 on or before
22 May 2016.
Performance rights
with a vesting date
850,000 of 30 June 2016.
529,845 Performance rights
226,342 with a vesting date
172,776 of 30 June 2017.
73,807 Performance rights
Number and +class 3,200,000 with a vesting date
of all +securities 1,461,429 of 30 June 2018
not quoted on ASX 1,491,989 Performance rights
(including the +securities 1,982,545 with an expiry of
9 in section 2 if applicable) 366,945 22 December 2020.
------------ -------------------------------
10 Dividend policy (in n/a
the case of a trust,
distribution policy)
on the increased capital
(interests)
---------------------------------------------
Part 2 -- Pro rata issue
11 Is security holder
approval required?
12 Is the issue renounceable
or non-renounceable?
13 Ratio in which the
+securities will be
offered
14 +Class of +securities
to which the offer
relates
15 +Record date to determine
entitlements
16 Will holdings on different
registers (or subregisters)
be aggregated for calculating
entitlements?
17 Policy for deciding
entitlements in relation
to fractions
18 Names of countries
in which the entity
has security holders
who will not be sent
new offer documents
Note: Security holders
must be told how their
entitlements are to
be dealt with.
Cross reference: rule
7.7.
19 Closing date for receipt
of acceptances or renunciations
20 Names of any underwriters
21 Amount of any underwriting
fee or commission
22 Names of any brokers
to the issue
23 Fee or commission payable
to the broker to the
issue
24 Amount of any handling
fee payable to brokers
who lodge acceptances
or renunciations on
behalf of security
holders
25 If the issue is contingent
on security holders'
approval, the date
of the meeting
26 Date entitlement and
acceptance form and
offer documents will
be sent to persons
entitled
27 If the entity has issued
options, and the terms
entitle option holders
to participate on exercise,
the date on which notices
will be sent to option
holders
28 Date rights trading
will begin (if applicable)
29 Date rights trading
will end (if applicable)
30 How do security holders
sell their entitlements
in full through a broker?
31 How do security holders
sell part of their
entitlements through
a broker and accept
for the balance?
32 How do security holders
dispose of their entitlements
(except by sale through
a broker)?
33 +Issue date
Part 3 -- Quotation of securities
You need only complete this section if you are applying for
quotation of securities
34 Type of +securities
(tick one)
(a) x +Securities described in Part 1
(b) All other +securities
Example: restricted securities at the end of the
escrowed period, partly paid securities that become
fully paid, employee incentive share securities
when restriction ends, securities issued on expiry
or conversion of convertible securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing
the information or documents
35 If the +securities are +equity securities, the
names of the 20 largest holders of the additional
+securities, and the number and percentage of
additional +securities held by those holders
36 If the +securities are +equity securities, a distribution
schedule of the additional +securities setting
out the number of holders in the categories
1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over
37 A copy of any trust deed for the additional +securities
(MORE TO FOLLOW) Dow Jones Newswires
November 20, 2015 02:00 ET (07:00 GMT)
Entities that have ticked box 34(b)
38 Number of +securities
for which +quotation
is sought
39 +Class of +securities
for which quotation
is sought
-----------------------------
40 Do the +securities
rank equally in all
respects from the +issue
date with an existing
+class of quoted +securities?
If the additional +securities
do not rank equally,
please state:
* the date from which they do
* the extent to which they participate for the next
dividend, (in the case of a trust, distribution) or
interest payment
* the extent to which they do not rank equally, other
than in relation to the next dividend, distribution
or interest payment
41 Reason for request
for quotation now
Example: In the case
of restricted securities,
end of restriction
period
(if issued upon conversion
of another +security,
clearly identify that
other +security)
-----------------------------
Number +Class
------------- ----------------
42 Number and +class of
all +securities quoted
on ASX (including the
+securities in clause
38)
------------- ----------------
Quotation agreement
1 +Quotation of our additional +securities is in ASX's absolute
discretion. ASX may quote the +securities on any conditions it
decides.
2 We warrant the following to ASX.
-- The issue of the +securities to be quoted complies with the
law and is not for an illegal purpose.
-- There is no reason why those +securities should not be granted +quotation.
-- An offer of the (+) securities for sale within 12 months
after their issue will not require disclosure under section 707(3)
or section 1012C(6) of the Corporations Act.
Note: An entity may need to obtain appropriate warranties from
subscribers for the securities in order to be able to give this
warranty
-- Section 724 or section 1016E of the Corporations Act does not
apply to any applications received by us in relation to any
+securities to be quoted and that no-one has any right to return
any +securities to be quoted under sections 737, 738 or 1016F of
the Corporations Act at the time that we request that the
+securities be quoted.
-- If we are a trust, we warrant that no person has the right to
return the +securities to be quoted under section 1019B of the
Corporations Act at the time that we request that the +securities
be quoted.
3 We will indemnify ASX to the fullest extent permitted by law
in respect of any claim, action or expense arising from or
connected with any breach of the warranties in this agreement.
4 We give ASX the information and documents required by this
form. If any information or document is not available now, we will
give it to ASX before +quotation of the +securities begins. We
acknowledge that ASX is relying on the information and documents.
We warrant that they are (will be) true and complete.
Sign here: Pauline Carr Date: 20/11/2015
Joint Company Secretary
== == == == ==
Appendix 3B - Annexure 1
Calculation of placement capacity under rule 7.1 and rule 7.1A
for eligible entities
Introduced 01/08/12 Amended 04/03/13
Part 1
Rule 7.1 - Issues exceeding 15% of capital
----------------------------------------------------------------------------
Step 1: Calculate "A", the base figure from which the
placement capacity is calculated
----------------------------------------------------------------------------
Insert number of fully paid
+ordinary securities on issue
12 months before the +issue
date or date of agreement
to issue 807,845,616
-------------------------------------------------------------- ------------
Add the following:
* Number of fully paid +ordinary securities issued in 1,701,177
that 12 month period under an exception in rule 7.2
Nil
* Number of fully paid +ordinary securities issued in Nil
that 12 month period with shareholder approval
* Number of partly paid +ordinary securities that
became fully paid in that 12 month period
Note:
* Include only ordinary securities here - other classes
of equity securities cannot be added
* Include here (if applicable) the securities the
subject of the Appendix 3B to which this form is
annexed
* It may be useful to set out issues of securities on
different dates as separate line items
-------------------------------------------------------------- ------------
Subtract the number of fully Nil
paid +ordinary securities
cancelled during that 12
month period
-------------------------------------------------------------- ------------
"A" 809,546,793
-------------------------------------------------------------- ------------
Step 2: Calculate 15% of "A"
----------------------------------------------------------------------------------------------
"B" 0.15
[Note: this value cannot be
changed]
------------------------------------------------------------- -------------------------------
Multiply "A" by 0.15 121,432,019
------------------------------------------------------------- -------------------------------
Step 3: Calculate "C", the amount of placement capacity
under rule 7.1 that has already been used
----------------------------------------------------------------------------------------------
Insert number of +equity Nil
securities issued or agreed
to be issued in that 12 month
period not counting those
issued:
* Under an exception in rule 7.2
* Under rule 7.1A
* With security holder approval under rule 7.1 or rule
7.4
Note:
* This applies to equity securities, unless
specifically excluded - not just ordinary securities
* Include here (if applicable) the securities the
subject of the Appendix 3B to which this form is
annexed
* It may be useful to set out issues of securities on
different dates as separate line items
------------------------------------------------------------- -------------------------------
"C" Nil
------------------------------------------------------------- -------------------------------
Step 4: Subtract "C" from ["A" x "B"] to calculate remaining
placement capacity under rule 7.1
----------------------------------------------------------------------------------------------
"A" x 0.15
Note: number must be same
as shown in Step 2 121,432,019
------------------------------------------------------------- -------------------------------
Subtract "C" Nil
Note: number must be same
as shown in Step 3
------------------------------------------------------------- -------------------------------
Total ["A" x 0.15] - "C" 121,432,019
Note: this is the remaining
placement capacity under rule
7.1
------------------------------------------------------------- -------------------------------
Part 2
Rule 7.1A - Additional placement capacity for eligible
entities
--------------------------------------------------------------------------------------------
Step 1: Calculate "A", the base figure from which the
placement capacity is calculated
--------------------------------------------------------------------------------------------
"A"
Note: number must be same
as shown in Step 1 of Part
1 809,546,793
-------------------------------------------------------------- ----------------------------
Step 2: Calculate 10% of "A"
--------------------------------------------------------------------------------------------
"D" 0.10
Note: this value cannot be
changed
-------------------------------------------------------------- ----------------------------
Multiply "A" by 0.10 80,954,679
-------------------------------------------------------------- ----------------------------
Step 3: Calculate "E", the amount of placement capacity
under rule 7.1A that has already been used
--------------------------------------------------------------------------------------------
(MORE TO FOLLOW) Dow Jones Newswires
November 20, 2015 02:00 ET (07:00 GMT)
Wolf Minerals (LSE:WLFE)
Historical Stock Chart
From Apr 2024 to May 2024
Wolf Minerals (LSE:WLFE)
Historical Stock Chart
From May 2023 to May 2024